<img height="1" width="1" src="https://www.facebook.com/tr?id=302523247453154&amp;ev=PageView &amp;noscript=1">
Skip to content
English
  • There are no suggestions because the search field is empty.

GPCCMP FAQ - Specific Patient Groups & Edge Cases

 

Categories:

Understanding GPCCMP & Key Changes – Overview of the GP Chronic Care Management Program and what’s new under GPCCMP.

Transitioning Existing Patients & Plans – How to move existing care plan patients smoothly into GPCCMP.

Staff Roles & Responsibilities – Clarifies who does what in GPCCMP workflows, from GPs to nurses and admin staff.

Practice Management & Clinical Software – Guides for using clinical software and Cubiko tools to support GPCCMP workflows.

Patient Communication & Operational Planning – Templates and tips for engaging patients and planning care delivery efficiently.

MyMedicare Requirements – What practices and patients need to know about MyMedicare registration and eligibility.

MBS Item Numbers & Billing – Understand which MBS items apply, how to claim correctly and avoid common billing errors.

GPCCMP Plan Creation & Reviews – Step-by-step guidance for creating, reviewing and updating GP Chronic Care Management Plans.

Financial Strategy & Practice Efficiency – Practical tips to improve billing accuracy, profitability and workflow efficiency.

Compliance & Quality Assurance – Stay compliant with RACGP, Medicare and MyMedicare requirements when delivering care plans.

Allied Health Referrals Under GPCCMP – How to manage allied health referrals linked to GP Chronic Care Management Plans.


 

When is a GPCCMP required for domiciliary medication management reviews?

The Bottom Line:

A GPCCMP will become a mandatory requirement for patients to access Domiciliary Medication Management Reviews (DMMR) from July 1st, 2027. This provides a clear transition period to ensure all patients needing these reviews are integrated into the new GPCCMP framework, with fees of $180.65 for GPs and $125.30 for PMPs.
 

The Facts:

  • From 1 July 2027, a GP Chronic Condition Management Plan (GPCCMP) will be required to access domiciliary medication management reviews (MBS items 245 and 900)
  • This requirement is in addition to the existing criteria for MBS items 245 and 900
  • Patients with an existing GPMP and/or TCA prior to 1 July 2025 can continue to access DMMRs through the MBS until 30 June 2027
  • After 1 July 2027, only patients with a GPCCMP will be eligible to access DMMRs through the MBS
  • Item 900 (GP participation in DMMR) has a fee of $180.65 with 100% benefit, and item 245 (PMP participation) has corresponding fees
  • These services can be claimed once every 12 months for any particular patient, except if there has been a significant change in the patient's condition or medication regimen requiring a new DMMR
Sources: Upcoming Changes to Chronic Disease Management Framework – Overview – Factsheet, page 2; Upcoming Changes to Chronic Disease Management MBS Items – Transition Arrangements for Existing Patients – Factsheet, page 1; MBS Online explanatory note AN.0.52; MBS Online explanatory note AN.15.3
 

How have medication review arrangements changed now that GPCCMP is in place?

 

The Bottom Line:

While the core Domiciliary Medication Management Review (DMMR) items themselves haven't changed, the main shift is that from July 1, 2027, a patient will need a GPCCMP to access these services. This solidifies the GPCCMP as the central framework for chronic condition management, including structured medication reviews with substantial fees justifying the comprehensive approach.
 

The Facts:

  • From 1 July 2027, a GP Chronic Condition Management Plan (GPCCMP) will be required to access domiciliary medication management reviews (MBS items 245 and 900)
  • This requirement is in addition to the existing criteria for MBS items 245 and 900
  • Patients with a GPMP and/or TCA in place prior to 1 July 2025 can continue to access these services under those plans until 30 June 2027
  • The DMMR process remains the same: GP assessment, referral to community pharmacy or accredited pharmacist, discussion of results, development of written medication management plan, and provision to patient's chosen pharmacy
  • Services are claimable once every 12 months per patient, with exceptions for significant changes in condition or medication regimen
Sources: Upcoming Changes to Chronic Disease Management Framework – Overview – Factsheet, page 2; Upcoming Changes to Chronic Disease Management MBS Items – Transition Arrangements for Existing Patients – Factsheet, page 1; MBS Online explanatory note AN.0.52; MBS Online explanatory note AN.15.3
 

Links and Resources:

Role-Based Implementation Guides:
Practice Resources:
Official Information:

Are there any other MBS services that now require a GPCCMP — or are expected to soon?

 

The Bottom Line:

Beyond the main chronic disease management changes, the GPCCMP requirements are quite focused. From July 2027, you'll need a GPCCMP for ongoing allied health services and domiciliary medication management reviews, but that's essentially it.
 

The Facts:

  • From 1 July 2027, a GP chronic condition management plan will be required for ongoing access to allied health services
  • From 1 July 2027, a GP chronic condition management plan will be required to access domiciliary medication management reviews (items 245 and 900)
  • These changes do not affect multidisciplinary care plan items (231, 232, 729, 731, 92026, 92027, 92057, 92058)
  • Individual allied health services (up to 5 per calendar year, 10 for Aboriginal and Torres Strait Islander patients) require a GPCCMP that has been prepared or reviewed in the previous 18 months
  • Group allied health services for type 2 diabetes management continue to be available with a GPCCMP
  • Practice nurse and Aboriginal and Torres Strait Islander health practitioner services (items 10997, 93201, 93203) require a GPCCMP and are limited to 5 services per calendar year
  • Aboriginal and Torres Strait Islander health services (items 10950, 81300, 93000, 93013, 93048, 93061) are available to patients with a GPCCMP, with fees of $72.65 and 85% benefit ($61.80) for most services
Sources: RACGP Summary of changes to Chronic Disease Management (CDM) Framework, page 2; Upcoming Changes to Chronic Disease Management Framework – Overview – Factsheet, page 2; MBS Online explanatory note AN.15.3; MBS Online explanatory note AN.15.5, AN.15.6
 

Links and Resources:

Role-Based Implementation Guides:
Practice Resources:
Official Information:

What happens to the 8 group sessions for Type 2 Diabetes under the new system?

The Bottom Line:

Patients with a GPCCMP can continue to access group services for type 2 diabetes management. The 8 sessions per calendar year remain available across dietetics, diabetes education, and exercise physiology services, with assessment fees of $93.25 and individual group session fees of $23.20, ensuring these vital services continue uninterrupted under the new framework.
 

The Facts:

  • Patients can access up to 8 group services for the management of type 2 diabetes per calendar year
  • This access is provided following an assessment of their suitability for group dietetics, diabetes education, or exercise physiology services
  • These services are available where they are consistent with the patient's GPCCMP
  • The item descriptors for these services have been updated due to the removal of GPMPs and TCAs, and the commencement of GPCCMPs
  • Assessment for group services (items 81100, 81110, 81120) has a fee of $93.25 with 85% benefit ($79.30), payable once per calendar year
  • Individual group sessions (items 81105, 81115, 81125) have a fee of $23.20 with 85% benefit ($19.75), to a maximum of 8 sessions per calendar year
  • Services are provided to groups of 2-12 patients and require at least 60 minutes duration
  • Group services are available for patients with type 2 diabetes who have either a GPCCMP or are residents of an aged care facility with a multidisciplinary care plan
Sources: Upcoming Changes to Chronic Disease Management Framework – MBS Items for GP Chronic Condition Management Plans – Factsheet, page 2; MBS Online explanatory note AN.15.3; MBS Online explanatory note AN.15.5, AN.15.6, MN.9.1, MN.9.2
 

Links and Resources:

Role-Based Implementation Guides:
Practice Resources:
Official Information:

How do GPCCMP changes affect specialised clinics (skin cancer, aesthetics, etc.)?

The Bottom Line:

The GPCCMP framework is specifically designed for the structured management of chronic medical conditions that are long-term or terminal. Since specialised clinics like skin cancer or aesthetics generally fall outside the scope of chronic condition management as defined by the MBS, these clinics are unlikely to be directly affected by the GPCCMP requirements.
 

The Facts:

  • A GPCCMP is available to patients with at least one medical condition that has been (or is likely to be) present for at least 6 months or is terminal
  • It is up to the GP or PMP's clinical judgment to determine whether an individual patient with a chronic condition would benefit from a GPCCMP
  • The GPCCMP framework specifically targets chronic disease management and associated allied health services
  • There is no specific list of eligible conditions; clinical judgment determines appropriateness based on the chronic nature and management benefit
Sources: Upcoming Changes to Chronic Disease Management Framework – MBS Items for GP Chronic Condition Management Plans – Factsheet, page 3; Upcoming Changes to Chronic Disease Management Framework – Overview – Factsheet, page 2; MBS Online explanatory note AN.0.47; MBS Online explanatory note AN.15.3, AN.15.4

Links and Resources:

Role-Based Implementation Guides:
Practice Resources:
Official Information:

How do we handle NDIS or DVA patients under the new GPCCMP structure?

The Bottom Line:

The new GPCCMP framework streamlines chronic disease management by replacing the old GPMP and TCA items. The good news is that these changes do not affect other MBS-supported allied health services such as Mental Health Treatment Plans or DVA services, which continue under their existing frameworks and item numbers, maintaining separate pathways for these specific patient groups.
 

The Facts:

  • The GPCCMP requirements do not apply to other MBS-supported allied health services such as Mental Health Treatment Plans, Eating Disorder Plans, Palliative Care, and DVA services
  • These other plans remain under their existing frameworks and item numbers
  • Specifically, the new referral requirements do not apply to Better Access psychological therapy services, focussed psychological strategies (allied mental health) services, eating disorder allied health services, or diagnostic audiology services
  • NDIS patients may still benefit from GPCCMPs for chronic condition management where clinically appropriate, but their NDIS-funded services continue under existing arrangements
  • The GPCCMP framework operates parallel to, rather than replacing, other specific health service frameworks
  • Patients with mental health conditions or eating disorders may be eligible for treatment through the Better Access mental health items or eating disorder items, which have specific eligibility criteria detailed in item-specific explanatory notes
Sources: Upcoming Changes to Chronic Disease Management Framework – Referral Arrangements for Allied Health Services – Factsheet, page 3; MBS Online explanatory note AN.15.3; MBS Online explanatory note AN.0.56, AN.36.2, AN.15.6
 

Links and Resources:

Role-Based Implementation Guides:
Practice Resources:
Official Information:

Do the changes affect multidisciplinary care plan items or other multidisciplinary services available to patients?

The Bottom Line:

These changes do not affect existing multidisciplinary care plan items (like those for residential aged care facilities), which continue under their current framework with fees of $65.70 for PMPs and $82.10 for GPs.
 

The Facts:

  • The changes to the chronic disease management framework do not affect multidisciplinary care plan items (231, 232, 729, 731, 92026, 92027, 92057, 92058)
  • GPCCMPs are not available to patients in residential aged care facilities; allied health services for these patients are available through a multidisciplinary care plan
  • The requirement to consult with at least two collaborating providers, as described under the current Team Care Arrangements, will be removed
  • There is no requirement for allied health providers to confirm acceptance of the referral or provide input into the preparation of the GPCCMP
  • Multidisciplinary care plans allow the general practitioner/prescribed medical practitioner to contribute to a plan which may be coordinated by another provider
  • Items 232, 731, 92027 and 92058 are available for patients living in a residential aged care facility; items 231, 729, 92026 and 92057 are available for patients not in residential aged care
Sources: RACGP Summary of changes to Chronic Disease Management (CDM) Framework, page 2; Upcoming Changes to Chronic Disease Management Framework – Referral Arrangements for Allied Health Services – Factsheet, pages 1, 3; Upcoming Changes to Chronic Disease Management Framework – MBS Items for GP Chronic Condition Management Plans – Factsheet, pages 1, 3, 4; Upcoming Changes to Chronic Disease Management Framework – Overview – Factsheet, page 2; MBS Online explanatory note AN.15.3; MBS Online explanatory note AN.15.7, AN.15.8
 

Links and Resources:

Role-Based Implementation Guides:
Practice Resources:
Official Information:

Can a GPCCMP be created for emergency or urgent chronic condition management needs?

 

The Bottom Line:

While the GPCCMP is designed for a structured, ongoing approach to chronic conditions, the good news is that a plan can be prepared or reviewed earlier than the usual timeframe if exceptional circumstances apply. This built-in flexibility allows you to adapt to urgent situations where a new plan or review is clinically relevant outside the typical 3-month or 12-month intervals, with full fee entitlements maintained.
 

The Facts:

  • Unless exceptional circumstances apply, a GPCCMP can be prepared once every 12 months if it is clinically relevant
  • Reviews can be conducted once every 3 months, if clinically relevant, unless exceptional circumstances apply
  • Plans may be prepared or reviewed earlier if exceptional circumstances apply
  • The MBS fee structure remains the same regardless of timing: $156.55 for GPs and $125.30 for PMPs for both preparation and review
  • Clinical relevance and exceptional circumstances are determined by the GP or prescribed medical practitioner's professional judgment
Sources: RACGP Summary of changes to Chronic Disease Management (CDM) Framework, page 2; Upcoming Changes to Chronic Disease Management Framework – MBS Items for GP Chronic Condition Management Plans – Factsheet, pages 2, 4; Upcoming Changes to Chronic Disease Management Framework – Overview – Factsheet, page 2; MBS Online explanatory note AN.0.47; MBS Online explanatory note AN.15.3, AN.15.4
 
 

Disclaimer: This FAQ is for general information only and reflects our understanding of upcoming changes to chronic disease management frameworks at the time of publication. For the most accurate and up-to-date guidance, please refer to official sources such as the Department of Health and Aged Care or Medicare. Cubiko is not responsible for any actions taken based on this information.